Since transforming growth factor‐beta 1 (TGF‐β1) has been identified as one of the critical factors of bad prognosis in many tumor types,20 TGF‐β1 blockades have emerged as a potential cancer therapy strategy. This evidence concerns the gene TGFB1 and neoplasm.